European Respiratory Journal

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

March

ERJ March Podcast: World TB Day 2017 Eur Respir J , 49 (3) 17E4903; DOI: 10.1183/13993003.E4903-2017
Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding Robert B. Banzett, Shakeeb H. Moosavi Eur Respir J , 49 (3) 1602473; DOI: 10.1183/13993003.02473-2016
Simple functional tests in COPD: stand up and be counted! Matthew Maddocks, Claire M. Nolan, William D-C. Man Eur Respir J , 49 (3) 1700104; DOI: 10.1183/13993003.00104-2017
The new “Hesitation Blues”: initiating Mycobacterium avium complex lung disease therapy David E. Griffith, Julie V. Philley Eur Respir J , 49 (3) 1700110; DOI: 10.1183/13993003.00110-2017
Assessing the potential pandemic risk of recent avian influenza viruses Ian G. Barr Eur Respir J , 49 (3) 1602517; DOI: 10.1183/13993003.02517-2016
Acute effects of bronchial thermoplasty: a matter of concern or an indicator of possible benefit to small airways? Louis-Philippe Boulet, Michel Laviolette Eur Respir J , 49 (3) 1700029; DOI: 10.1183/13993003.00029-2017
Obstructive sleep apnoea in acute coronary syndrome: the invisible threat? Michael Arzt, Andrea Hetzenecker, Patrick Lévy Eur Respir J , 49 (3) 1602539; DOI: 10.1183/13993003.02539-2016
Malignant pleural mesothelioma: new treatments, new hopes? Arnaud Scherpereel Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Assessment of Burden of COPD (ABC) tool: perception versus evidence Sarah Houben-Wilke, Frits M.E. Franssen, Ineke Kok, Henk J. Otten, Johan P. Wempe, Jan H. Vercoulen Eur Respir J , 49 (3) 1602382; DOI: 10.1183/13993003.02382-2016
Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline Emanuele Pontali, Lia D'Ambrosio, Rosella Centis, Giovanni Sotgiu, Giovanni Battista Migliori Eur Respir J , 49 (3) 1700146; DOI: 10.1183/13993003.00146-2017
Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated Mohammed A. Yassin, Ernesto Jaramillo, Eliud Wandwalo, Dennis Falzon, Anna Scardigli, Osamu Kunii, Karin Weyer Eur Respir J , 49 (3) 1700081; DOI: 10.1183/13993003.00081-2017
The Art of Breathing: Diffusion Tom Kotsimbos, Gary P. Anderson Eur Respir J , 49 (3) 1704903; DOI: 10.1183/13993003.04903-2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha, Alvar Agusti Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline Jadwiga A. Wedzicha, Marc Miravitlles, John R. Hurst, Peter M.A. Calverley, Richard K. Albert, Antonio Anzueto, Gerard J. Criner, Alberto Papi, Klaus F. Rabe, David Rigau, Pawel Sliwinski, Thomy Tonia, Jørgen Vestbo, Kevin C. Wilson, Jerry A. Krishnan Eur Respir J , 49 (3) 1600791; DOI: 10.1183/13993003.00791-2016
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update Dennis Falzon, Holger J. Schünemann, Elizabeth Harausz, Licé González-Angulo, Christian Lienhardt, Ernesto Jaramillo, Karin Weyer Eur Respir J , 49 (3) 1602308; DOI: 10.1183/13993003.02308-2016
A multicentre validation of the 1-min sit-to-stand test in patients with COPD Sarah Crook, Gilbert Büsching, Konrad Schultz, Nicola Lehbert, Danijel Jelusic, Stephan Keusch, Michael Wittmann, Michael Schuler, Thomas Radtke, Martin Frey, Alexander Turk, Milo A. Puhan, Anja Frei Eur Respir J , 49 (3) 1601871; DOI: 10.1183/13993003.01871-2016
Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD Marie T. Williams, David John, Peter Frith Eur Respir J , 49 (3) 1600773; DOI: 10.1183/13993003.00773-2016
Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD Gunnar R. Husebø, Rune Grønseth, Lorena Lerner, Jeno Gyuris, Jon A. Hardie, Per S. Bakke, Tomas M. Eagan Eur Respir J , 49 (3) 1601298; DOI: 10.1183/13993003.01298-2016
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Louise J.P Persson, Marianne Aanerud, Jon A. Hardie, Roy Miodini Nilsen, Per S. Bakke, Tomas M. Eagan, Pieter S. Hiemstra Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Rosa Munoz-Cano, Alfons Torrego, Joan Bartra, Jaime Sanchez-Lopez, Rosa Palomino, Cesar Picado, Antonio Valero Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Human bronchial epithelium orchestrates dendritic cell activation in severe asthma Delphine Gras, Asuncion Martinez-Anton, Arnaud Bourdin, Celine Garulli, Laure de Senneville, Isabelle Vachier, Joana Vitte, Pascal Chanez Eur Respir J , 49 (3) 1602399; DOI: 10.1183/13993003.02399-2016
Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma Marie-Pierre Debray, Marie-Christine Dombret, Marina Pretolani, Gabriel Thabut, Loubna Alavoine, Pierre-Yves Brillet, Camille Taillé, Antoine Khalil, Pascal Chanez, Michel Aubier Eur Respir J , 49 (3) 1601565; DOI: 10.1183/13993003.01565-2016
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis Helen White, Nicola Shaw, Sarah Denman, Kim Pollard, Sarah Wynne, Daniel Gavin Peckham Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016
Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course Ji An Hwang, Sunyoung Kim, Kyung-Wook Jo, Tae Sun Shim Eur Respir J , 49 (3) 1600537; DOI: 10.1183/13993003.00537-2016
Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract Kenrie P. Y. Hui, Louisa L. Y. Chan, Denise I. T. Kuok, Chris K. P. Mok, Zi-feng Yang, Run-feng Li, Geraldine S. M. Luk, Elaine F. Lee, Jimmy C. C. Lai, Hui-ling Yen, Huachen Zhu, Yi Guan, John M. Nicholls, J. S. Malik Peiris, Michael C. W. Chan Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Predictors of obstructive sleep apnoea in patients admitted for acute coronary syndrome Jordi de Batlle, Cecilia Turino, Alicia Sánchez-de-la-Torre, Jorge Abad, Joaquín Duran-Cantolla, R. Douglas McEvoy, Nick A. Antic, Olga Mediano, Valentín Cabriada, Maria José Masdeu, Joaquín Teran, Joan Valls, Ferran Barbé, Manuel Sánchez-de-la-Torre on behalf of the Spanish Sleep Group Eur Respir J , 49 (3) 1600550; DOI: 10.1183/13993003.00550-2016
Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma Marc de Perrot, Zhi Dong, Penelope Bradbury, Demetris Patsios, Shaf Keshavjee, Natasha B. Leighl, Andrew Hope, Ronald Feld, John Cho Eur Respir J , 49 (3) 1601428; DOI: 10.1183/13993003.01428-2016
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû, Marie Lachâtre, Dhiba Marigot-Outtandy, Christine Bernard, Nicolas Veziris, Jérôme Robert, Yazdan Yazdanpanah, Eric Caumes, Mathilde Fréchet-Jachym for the French MDR-TB Management Group Eur Respir J , 49 (3) 1601799; DOI: 10.1183/13993003.01799-2016
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies Eur Respir J , 49 (3) 1600803; DOI: 10.1183/13993003.00803-2016
Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil Margareth Dalcolmo, Regina Gayoso, Giovanni Sotgiu, Lia D'Ambrosio, Jorge L. Rocha, Liamar Borga, Fatima Fandinho, Jose U. Braga, Vera M.N. Galesi, Draurio Barreira, Denise A. Sanchez, Fernanda Dockhorn, Rosella Centis, Jose A. Caminero, Giovanni B. Migliori Eur Respir J , 49 (3) 1602445; DOI: 10.1183/13993003.02445-2016
Biological therapies in nonsmall cell lung cancer Jon Zugazagoitia, Sonia Molina-Pinelo, Fernando Lopez-Rios, Luis Paz-Ares Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Physiological and clinical relevance of exercise ventilatory efficiency in COPD J. Alberto Neder, Danilo C. Berton, Flavio F. Arbex, Maria Clara Alencar, Alcides Rocha, Priscila A. Sperandio, Paolo Palange, Denis E. O'Donnell Eur Respir J , 49 (3) 1602036; DOI: 10.1183/13993003.02036-2016
Small airway dysfunction in well-treated never-smoking HIV-infected individuals Andreas Ronit, Inger Hee Mathiesen, Marco Gelpi, Thomas Benfield, Jan Gerstoft, Tanja Pressler, Anders Christiansen, Jens Lundgren, Jørgen Vestbo, Susanne Dam Nielsen Eur Respir J , 49 (3) 1602186; DOI: 10.1183/13993003.02186-2016
Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study Yu Pang, Yaoju Tan, Jin Chen, Yanming Li, Huiwen Zheng, Yuanyuan Song, Yanlin Zhao Eur Respir J , 49 (3) 1601429; DOI: 10.1183/13993003.01429-2016
Impaired exercise ventilatory efficiency in smokers with low transfer factor but normal spirometry Gisele Walter Barbosa, J. Alberto Neder, Karina Utida, Denis E. O'Donnell, Paulo de Tarso Müller Eur Respir J , 49 (3) 1602511; DOI: 10.1183/13993003.02511-2016
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis Angira Dasgupta, Melanie Kjarsgaard, Dante Capaldi, Katherine Radford, Fernando Aleman, Colm Boylan, Leonard C. Altman, Thomas N. Wight, Grace Parraga, Paul M. O'Byrne, Parameswaran Nair Eur Respir J , 49 (3) 1602486; DOI: 10.1183/13993003.02486-2016
Exercise-induced changes in QT interval are smaller in COPD patients and have no impact on mortality Afroditi K. Boutou, Russell Franks, Divya Mohan, Lilian Mantziari, Tom Wong, Nicholas S. Hopkinson, Michael I. Polkey Eur Respir J , 49 (3) 1602394; DOI: 10.1183/13993003.02394-2016
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India Zarir F. Udwadia, Shashank Ganatra, Jai B. Mullerpattan Eur Respir J , 49 (3) 1601699; DOI: 10.1183/13993003.01699-2016
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors Nicolas Veziris, Christine Bernard, Lorenzo Guglielmetti, Damien Le Du, Dhiba Marigot-Outtandy, Marie Jaspard, Eric Caumes, Isabelle Lerat, Christophe Rioux, Yazdan Yazdanpanah, Angelica Tiotiu, Nadine Lemaitre, Florence Brossier, Vincent Jarlier, Jerome Robert, Wladimir Sougakoff, Alexandra Aubry on behalf of the CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA Eur Respir J , 49 (3) 1601719; DOI: 10.1183/13993003.01719-2016
Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections Silvan Vesenbeckh, Nicolas Schönfeld, David Krieger, Gudrun Bettermann, Torsten Thomas Bauer, Holger Rüssmann, Harald Mauch Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis Anne-Fleur Louise Van der Paardt, Onno W. Akkerman, Gina Gualano, Fabrizio Palmieri, Lina Davies Forsman, Alena Aleksa, Simon Tiberi, Wiel C.M. de Lange, Mathieu S. Bolhuis, Alena Skrahina, Dick van Soolingen, Jos G.W. Kosterink, Giovanni Battista Migliori, Tjip S. van der Werf, Jan-Willem C. Alffenaar Eur Respir J , 49 (3) 1601612; DOI: 10.1183/13993003.01612-2016
Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union Marieke J. van der Werf, Vahur Hollo, Csaba Ködmön, Masoud Dara, Mike Catchpole Eur Respir J , 49 (3) 1601992; DOI: 10.1183/13993003.01992-2016
Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China Peng Lu, Qiao Liu, Leonardo Martinez, Haitao Yang, Wei Lu, Xiaoyan Ding, Limei Zhu Eur Respir J , 49 (3) 1601558; DOI: 10.1183/13993003.01558-2016
Impact of interferon-? release assay on the latent tuberculosis cascade of care: a population-based study David Z. Roth, Lisa A. Ronald, Daphne Ling, Leslie Y. Chiang, Victoria J. Cook, Muhammad G. Morshed, James C. Johnston Eur Respir J , 49 (3) 1601546; DOI: 10.1183/13993003.01546-2016
Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis Els Van Kampenhout, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar, Laurien M.A. Oswald, Huib A.M. Kerstjens, Wiel C.M. de Lange, Tjip S. van der Werf, Onno W. Akkerman Eur Respir J , 49 (3) 1601724; DOI: 10.1183/13993003.01724-2016
Extent of transmission captured by contact tracing in a tuberculosis high endemic setting Karen Bjorn-Mortensen, Troels Lillebaek, Anders Koch, Bolette Soborg, Karin Ladefoged, Hans Christian Florian Sørensen, Thomas Andreas Kohl, Stefan Niemann, Aase Bengaard Andersen Eur Respir J , 49 (3) 1601851; DOI: 10.1183/13993003.01851-2016
Can tuberculosis patients in resource-constrained settings afford chest radiography? Debora Pedrazzoli, Marek Lalli, Delia Boccia, Rein Houben, Katharina Kranzer Eur Respir J , 49 (3) 1601877; DOI: 10.1183/13993003.01877-2016
Tuberculosis on the rise in southern Mozambique (1997–2012) Alberto L. García-Basteiro, Rafaela Miranda Ribeiro, Joe Brew, Charfudin Sacoor, Salomé Valencia, Helder Bulo, Frank Cobelens, Eusebio Macete Eur Respir J , 49 (3) 1601683; DOI: 10.1183/13993003.01683-2016
Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience Heorhi Sinkou, Henadz Hurevich, Valiantsin Rusovich, Liudmila Zhylevich, Dennis Falzon, Pierpaolo de Colombani, Andrei Dadu, Masoud Dara, Alistair Story, Alena Skrahina Eur Respir J , 49 (3) 1602049; DOI: 10.1183/13993003.02049-2016
QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool Arisu Kamada, Masaru Amishima Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016
Incident opioid drug use and adverse respiratory outcomes among older adults with COPD Magnus Ekström, Sabrina Bajwah, Miriam J. Johnson Eur Respir J , 49 (3) 1602311; DOI: 10.1183/13993003.02311-2016
Incident opioid use is associated with risk of respiratory harm in non-palliative COPD Nicholas T. Vozoris, Denis E. O'Donnell, Chaim Bell, Sudeep S. Gill, Paula A. Rochon Eur Respir J , 49 (3) 1602529; DOI: 10.1183/13993003.02529-2016